Bile acid diarrhoea

In this episode, Charlie Andrews speaks to Professor Julian Walters about bile acid malabsorption and diarrhoea. With up to a third of patients with diarrhoea-predominant IBS having underlying bile acid diarrhoea, and with diagnosis rates for this condition being low, this episode is an important one for anyone working in primary care. We explore the role...
Read More

Faecal calprotectin

In this episode, Charlie Andrews speaks to Dr James Turvill about faecal calprotectin use in primary care. Dr Turvill is a gastroenterologist based in York, who was instrumental in developing the NICE-approved and widely adopted York Faecal Calprotectin Care Pathway. What is calprotectin? When should we use it in primary care? How should we interpret...
Read More

IBS – dietary management and the 10-minute consultation…

Marianne Williams is an extremely experienced dietician, innovator, digital technology advocate and winner of the NHS England Allied Health Professional of the Year prize for 2018.   In this episode, Marianne shares her wealth of knowledge around all things IBS to discuss initial dietary management, the low FODMAPs diet, the role of probiotics, and gives us...
Read More

IBD Flare Management

In this episode Charlie Andrews speaks to Dr Kevin Barrett about IBD flare management.  On average, 50% of patients will flare annually, and often the GP surgery is the first port of call.  We therefore need to know how to assess and manage patients presenting with symptomatic IBD.  Kevin Barrett, IBD clinical champion for IBD...
Read More

Updated guidance on FIT testing in primary care

In this episode, Charlie Andrews speaks to Dr Kevin Monahan, lead author for the joint guidelines published by the BSG and ACPGBI in July 2022 outlining the role of FIT testing in patients with symptoms suggestive of colorectal cancer.  These guidelines have informed how we use FIT in primary care, and in this episode he...
Read More

Ingest episode 14 out now – Abnormal LFTs

Episode 14  Helen demystifies the commonly used tests for assessing for fibrosis in fatty liver disease, and how we can empower our nursing teams to assess for fatty liver disease when abnormal LFTs are identified at chronic disease reviews.  

Abnormal LFTs and non-alcoholic liver disease

Did you know that according to the British Liver Trust, up to 20% of the general population has non-alcoholic liver disease (‘fatty liver disease’) and the prevalence is predicted to rise over the coming years.  Morbidity associated with this can be significant, with a proportion of patients with fatty liver disease developing fibrosis of the...
Read More

Coeliac disease management and follow-up

Join Charlie Andrews in this episode where he speaks to Cristian Costas about the management of people diagnosed with coeliac disease.  Cristian is a dynamic dietician who is based in Bradford.  He is passionate about coeliac disease and runs an innovative dietician-led service for those with coeliac disease in his area.   Cristian shares with us...
Read More

Background to FIT testing in primary care

In primary care, we are increasingly using FIT (Faecal Immunochemical Testing) to assess the risk of bowel cancer in patients with lower gastrointestinal symptoms, whilst the latest PCN DES IIF (Impact and Investment Fund) has given FIT a prominent role in risk stratifying 2-week wait referrals to secondary care.   In this episode, Mo Thoufeeq, a...
Read More
PCSG Podcast Ingest
Skip to toolbar